The Clinicians’ Guide to Managing Immune-Related Adverse Events: An Interactive Algorithm Tool

Download All
This multifaceted program, which includes a text module and an interactive algorithm tool, equips clinicians with guideline-driven recommendations to inform their evaluation and management of immune-related adverse events resulting from checkpoint inhibition.
Jeffrey S. Weber, MD, PhD
Program Director
Michael Postow, MD
Osama E. Rahma, MD
Jeffrey S. Weber, MD, PhD


Using 2 real-world clinical scenarios, this commentary focuses on practical strategies to manage pulmonary and endocrine adverse events associated with checkpoint inhibition in melanoma.

Jeffrey S. Weber, MD, PhD Released: September 26, 2016

This commentary describes 2 cases from my clinic and our experience managing hepatic, neurologic, and hematologic adverse events in patients treated for melanoma with immune checkpoint inhibitors.

Michael Postow, MD Released: October 27, 2016

How do preexisting autoimmune conditions such as ulcerative colitis and rheumatoid arthritis affect management of melanoma with checkpoint inhibitors?

Osama E. Rahma, MD Released: February 8, 2017


In this CME-certified educational module, CCO’s expert faculty members highlight case-based examples to discuss the management of adverse events during checkpoint inhibitor therapy.

Jeffrey S. Weber, MD, PhD
Program Director
Michael Postow, MD Osama E. Rahma, MD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: March 3, 2017 Expired: No longer available for credit
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by an educational grant from
Merck & Co., Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings